BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3449792)

  • 1. Hepatic perfusion index and the evolution of liver metastases.
    Cooke DA; Parkin A; Wiggins P; Robinson PJ; Giles GR
    Nucl Med Commun; 1987 Dec; 8(12):970-2. PubMed ID: 3449792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic hepatic scintigraphy in colorectal cancer.
    Hemingway DM; Cooke TG; Warren H; Bessent RG; McKillop JH; McArdle CS
    Nucl Med Commun; 1995 Oct; 16(10):867-9. PubMed ID: 8570118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer.
    Ballantyne KC; Charnley RM; Perkins AC; Pye G; Whalley DR; Wastie ML; Hardcastle JD
    Nucl Med Commun; 1990 Jan; 11(1):23-8. PubMed ID: 2338966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of three indices of relative hepatic perfusion derived from dynamic liver scintigraphy.
    Britten AJ; Fleming JS; Flowerdew AD; Hunt TM; Taylor I; Karran SJ; Ackery DM
    Clin Phys Physiol Meas; 1990 Feb; 11(1):45-51. PubMed ID: 2323173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the hepatic perfusion index during the growth and development of experimental hepatic micrometastases.
    Nott DM; Grime JS; Yates J; Day DW; Baxter JN; Jenkins SA; Cooke TG
    Nucl Med Commun; 1987 Dec; 8(12):995-1000. PubMed ID: 3449796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic flow scintigraphy in evaluation of hepatic metastases in patients with gastrointestinal malignancy.
    Huguier M; Maheswari S; Toussaint P; Houry S; Mauban S; Mensch B
    Arch Surg; 1993 Sep; 128(9):1057-9. PubMed ID: 8368925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of the hepatic perfusion index for the detection of liver metastases.
    Perkins AC; Whalley DR; Ballantyne KC; Hardcastle JD
    Nucl Med Commun; 1987 Dec; 8(12):982-9. PubMed ID: 3449794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic perfusion index: colloid lung retention.
    Maughan J; Parkin A; Smith AH; Barker MC
    Nucl Med Commun; 1991 May; 12(5):465-6. PubMed ID: 2067752
    [No Abstract]   [Full Text] [Related]  

  • 9. A model of the hepatic perfusion index in the rat.
    Nott DM; Grime JS; Yates J; O'Driscoll MP; Baxter JN; Cooke TG; Jenkins SA
    Nucl Med Commun; 1987 Dec; 8(12):990-4. PubMed ID: 3449795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic liver scanning in cirrhosis.
    Bolton RP; Mairiang EO; Parkin A; Ware F; Robinson P; Losowsky MS
    Nucl Med Commun; 1988 Mar; 9(3):235-47. PubMed ID: 2838775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic hepatic scintigraphy: the effect of using high administered activity on reproducibility of hepatic perfusion index value.
    Hemingway DM; McCurrach G; Bessent RG; McKillop JH; Cooke TG
    Nucl Med Commun; 1991 Sep; 12(9):811-6. PubMed ID: 1945193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer.
    Hemingway DM; Cooke TG; McCurrach G; Bessent RG; Carter R; McKillop JH; McArdle CS
    Br J Cancer; 1992 May; 65(5):781-2. PubMed ID: 1586609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior visualization of hepatic metastases with Tc-99m disofenin as compared with Tc-99m sulfur colloid.
    Kochar AS
    Clin Nucl Med; 1984 May; 9(5):293. PubMed ID: 6744769
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic perfusion index: a multicentre trial.
    Maughan J; Parkin A; Smith AH; Barker MC; Robinson PJ; Finan P; Gilson P; Avison M
    Nucl Med Commun; 1992 Mar; 13(3):161-7. PubMed ID: 1557215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver disease.
    Goldberg JA; Fenner J; Bessent RG; Bradnam MS; McKillop JH; McKee RF; McArdle CS; Kerr DJ
    Nucl Med Commun; 1989 Aug; 10(8):557-66. PubMed ID: 2812638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Streaming" in portal vein. Its effect on the spread of metastases to the liver.
    Desai AG; Park CH; Schilling JF
    Clin Nucl Med; 1985 Aug; 10(8):556-9. PubMed ID: 4042506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatic metastases: comparison of EOE-13 computed tomography and scintigraphy.
    Miller DL; Rosenbaum RC; Sugarbaker PH; Vermess M; Willis M; Doppman JL
    AJR Am J Roentgenol; 1983 Nov; 141(5):931-5. PubMed ID: 6312788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scintigraphy of hepatic hemangiomas: the value of Tc-99m-labeled red blood cells: concise communication.
    Royal HD; Israel O; Parker JA; Kolodny GM
    J Nucl Med; 1981 Aug; 22(8):684-7. PubMed ID: 7264756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of the hepatic perfusion index in patients with colorectal cancer.
    Warren HW; Gallagher H; Hemingway DM; Angerson WJ; Bessent RG; Wotherspoon H; McArdle CS; Cooke TG
    Br J Surg; 1998 Dec; 85(12):1708-12. PubMed ID: 9876080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary scintigraphy with 99Tcm-HIDA and 99Tcm-sulphur colloid. Comparison of the abilities to demonstrate biliary obstruction and hepatic metastases.
    Pedersen SA; Oster-Jørgensen E; Schoubye J
    Eur J Nucl Med; 1980 Aug; 5(4):305-9. PubMed ID: 7398668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.